SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Panacea Biotec informs about resignation of director

10 Mar 2022 Evaluate
Panacea Biotec has informed that Shantanu Yeshwant Nalavadi, Non-Executive Nominee Director of the Company has, due to his professional commitments, tendered resignation from the Board of Directors of the Company vide his letter dated March 10, 2022. Shantanu Yeshwant Nalavadi was earlier nominated by Vistra ITCL (India)  acting as Debenture Trustee with respect to non-convertible debentures issued to India Resurgence Fund-Scheme 1, India Resurgence Fund-Scheme 2 and Piramal Enterprises which have been fully redeemed on March 03,2022. The said resignation has become effective from March 10, 2022. 

The above information is a part of company’s filings submitted to BSE.

Panacea Biotec Share Price

358.00 5.30 (1.50%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×